The global infection surveillance solutions market size reached US$ 580.9 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,177.7 Million by 2028, exhibiting a growth rate (CAGR) of 12.1% during 2023-2028.
Infection surveillance solutions assist healthcare personnel in collecting, analyzing, and interpreting data about patients who are suffering from different infections. They notify hospital internet protocol and enable doctors as well as nurses in treating patients by providing dissemination of information. They also help diagnose antibiotic-resistant organisms (AROs), lower respiratory tract infections, and prevent ventilator-associated pneumonia, urinary tract, surgical wound and central line bloodstream. In addition, infection surveillance solutions identify epidemics and offer accurate employee health details, surgical database, real-time medical records, shifts in microbial pathogens.
Infection Surveillance Solutions Market Trends:
The growing prevalence of hospital-acquired infections (HAIs) on account of poor hygienic conditions and negligence by medical staff represents one of the major factors driving the market. Moreover, governments of numerous countries are undertaking initiatives to enhance the quality of care and safety of patients and prevent HAIs. This, along with the rising healthcare expenditure and high adoption rate of improved IT systems in hospitals to maintain electronic healthcare records (EHR), is propelling the growth of the market. In addition, the growing geriatric population and the increasing number of surgeries worldwide are positively influencing the market of infection surveillance solutions. Apart from this, healthcare information and technology (IT) companies are introducing innovative solutions in data management, analytics, and infrastructures that provide convenient data collection of infections and epidemics. This, in confluence with several developments in surveillance solutions to aid medical staff in understanding the software and its usage, is strengthening the market growth. Other factors projected to offer lucrative growth opportunities to key players operating in the market are the increasing adoption of cloud-based software and the escalating demand for web-based solutions and mobile platforms.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global infection surveillance solutionsmarket report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on component, deployment type and end user.
Breakup by Component:
Breakup by Deployment Type:
Breakup by End User:
Ambulatory Service Centers
Breakup by Region:
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Baxter International Inc., Becton Dickinson and Company, Centrak Inc. (Halma plc), Cerner Corporation, CKM Healthcare Incorporated, Ecolab Inc., International Business Machines Corporation, Medexter Healthcare, Perahealth Inc., PointClickCare, Premier Inc. and Sunquest Information Systems Inc. (Roper Technologies Inc.).
Base Year of the Analysis
Component, Deployment Type, End User, Region
Asia Pacific, Europe, North America, Latin America, Middle East and Africa
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Baxter International Inc., Becton Dickinson and Company, Centrak Inc. (Halma plc), Cerner Corporation, CKM Healthcare Incorporated, Ecolab Inc., International Business Machines Corporation, Medexter Healthcare, Perahealth Inc., PointClickCare, Premier Inc. and Sunquest Information Systems Inc. (Roper Technologies Inc.)
10% Free Customization
Report Price and Purchase Option
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report
The global infection surveillance solutions market was valued at US$ 580.9 Million in 2022.
We expect the global infection surveillance solutions market to exhibit a CAGR of 12.1% during 2023-2028.
The rising prevalence of hospital-acquired infections (HAIs) due to poor hygienic conditions and
negligence by medical staff, is currently driving the global infection surveillance solutions market.
The sudden outbreak of the COVID-19 pandemic has led to rising demand for infection surveillance
solutions to analyze the spread of coronavirus infection and to offer accurate results, surgical database,
real-time medical records, etc.
Based on the component, the global infection surveillance solutions market can be segmented into
software and services. Currently, software holds the majority of the total market share.
Based on the deployment type, the global infection surveillance solutions market has been divided into
on-premises and cloud-based, where on-premises deployment currently exhibits a clear dominance in
Based on the end user, the global infection surveillance solutions market can be categorized into
hospitals, clinics, ambulatory service centers, specialty centers, and others. Among these, hospitals
currently account for the largest market share.
On a regional level, the market has been classified into North America, Asia Pacific, Europe, Latin
America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global infection surveillance solutions market include Baxter
International Inc., Becton Dickinson and Company, Centrak Inc. (Halma plc), Cerner Corporation, CKM
Healthcare Incorporated, Ecolab Inc., International Business Machines Corporation, Medexter
Healthcare, Perahealth Inc., PointClickCare, Premier Inc., and Sunquest Information Systems Inc. (Roper
Need more help?
Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.